Upstream ORFs control TNFR1 abundance and tissue tolerance to TNF
Science Immunology · 03.04.2026 · 11 (118)
DOI: 10.1126/sciimmunol.aeb6484 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 03.04.2026. Verfasst von Biao Ma und 11 weiteren Autor:innen. Beteiligte Einrichtung: Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK. Hauptthemen laut MEDLINE: Receptors, Tumor Necrosis Factor, Type I, Tumor Necrosis Factor-alpha, Open Reading Frames, Immune Tolerance. Die Arbeit nennt 60 Literaturangaben. Gefördert von: Wellcome, Cancer Research UK, Swiss National Science Foundation.
Abstract (Originalsprache)
Tumor necrosis factor (TNF) orchestrates immune responses but can also drive inflammation-associated tissue damage. However, the mechanisms governing tissue tolerance to TNF remain poorly understood. Here, we reveal that TNF receptor 1 (TNFR1) abundance is regulated by two upstream open reading frames (uORFs) in the 5′ untranslated region of TNFRSF1A and demonstrate that this is a key determinant of TNF tolerance. uORF2 dominantly limits TNFR1 translation, and its disruption increases TNFR1 levels, leading to excessive TNF-induced gene activation and cell death in cell culture. By contrast, uORF1 dynamically regulates TNFR1 levels in response to inflammatory and stress signals. In mice, uORF2 protects against TNF-driven systemic inflammatory response syndrome and liver pathology. We additionally report that the translation of other immune receptor messenger RNAs, including TLR4 , IFNAR1 , and IFNGR2 , is also controlled by uORFs. Thus, regulation of TNFR1 levels and possibly of other immune receptors emerges as a mechanism safeguarding against excessive immune responses and tissue damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Ludwig Institute for Cancer Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
- LEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
- Centre for Immuno-Oncology, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
- Ludwig Institute for Cancer Research, de Duve Institute, UCLouvain, Brussels, Belgium.
- WELBIO Department, WEL Research Institute, Brussels, Belgium.
ORCID-Profile: Biao Ma, Wenxin Lyu, John Rizk, Xiaoyue Han, Majken Kjær, Vinnycius Pereira Almeida, Malin Jessen, Carol Sze Ki Leung, Benoit J Van den Eynde, Xin Lu, Mads Gyrd-Hansen
Förderung
- Wellcome
- Cancer Research UK
- Swiss National Science Foundation
- Novo Nordisk Fonden
- Leo Foundation
Zitieren
APA
Ma, B., Lyu, W., Rizk, J., Han, X., Kjær, M., Pereira Almeida, V., Jessen, M., Sauerland, M. B., Leung, C. S. K., Van den Eynde, B. J., Lu, X., & Gyrd-Hansen, M. (2026). Upstream ORFs control TNFR1 abundance and tissue tolerance to TNF. Science Immunology, 11(118). https://doi.org/10.1126/sciimmunol.aeb6484
Vancouver
Ma B, Lyu W, Rizk J, Han X, Kjær M, Pereira Almeida V, et al. Upstream ORFs control TNFR1 abundance and tissue tolerance to TNF. Science Immunology. 2026;11(118). doi:10.1126/sciimmunol.aeb6484
BibTeX
@article{Ma2026,
author = {Ma, Biao and Lyu, Wenxin and Rizk, John and Han, Xiaoyue and Kjær, Majken and Pereira Almeida, Vinnycius and Jessen, Malin and Sauerland, Max Benjamin and Leung, Carol Sze Ki and Van den Eynde, Benoit J and Lu, Xin and Gyrd-Hansen, Mads},
title = {Upstream ORFs control TNFR1 abundance and tissue tolerance to TNF},
journal = {Science Immunology},
year = {2026},
volume = {11},
number = {118},
doi = {10.1126/sciimmunol.aeb6484}
}
EUVIMED